Latest filing published 03 Sept 2024 for PFIZER INC, €529k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Aamir Malik: trading record in brief
Aamir Malik (chief executive) discloses dealings in Pfizer Inc to SEC (Form 4). The record holds 2 filings, for trades running from 31 August 2021 to 31 August 2024.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 3 September 2024, reports a share grant of €529k in Pfizer Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Aamir Malik
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,195 shares@ US$29.01100.0% of flowCommon StockSEC:0001225208-24-008338:0
- 43,412 shares0Common StockSEC:0001225208-21-011947:0
2 of 2 declarations
